Oct 15, 2024
Nicolas Rouhana, Guest Speaker on BioTech Investment Trends at the European Angel Investment Summit 2024
arrow icon
arrow icon

The European Angel Investment Summit (EIAS), held in Brussels, Belgium, on October 15-16, 2024, marked a significant milestone as it celebrated the 25th anniversary of the European Business Angels Network (EBAN). This gathering brought together more than 400 stakeholders, including angel investors, entrepreneurs, policymakers, and industry experts, all united in their commitment to enhancing the startup ecosystem across Europe and rest of the world.

Over the two-day event, attendees engaged in a series of panels, workshops, and networking sessions designed to address current challenges and opportunities within the angel investment landscape. Key themes included the evolution of angel investing over the past quarter-century, innovative funding models, and the critical role of angels in supporting early-stage ventures. Dr. Nicolas Rouhana, Chairman and CEO of IM, was invited as a guest speaker on a panel about BioTech Investment Trends where he shared IM’s experiences and ideas on this topic, on perspectives from other markets and the role of public funding and incentives in de-risking early-stage, high-risk, R&D-intensive innovations like BioTech & MedTech.

The summit concluded with the EBAN General Assembly followed by board elections, where Dr. Rouhana was re-elected for two more years and a second mandate, once again positioning Lebanon and IM on the international scene of the investment landscape.

By commemorating its silver jubilee, the European Angel Investment Summit (EAIS) not only celebrated past achievements but also set a forward-looking agenda for the next generation of angel investors and startups.